Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
Add more filters










Publication year range
1.
Nature ; 2024 Jul 05.
Article in English | MEDLINE | ID: mdl-38969846
5.
Science ; 384(6698): 836, 2024 May 24.
Article in English | MEDLINE | ID: mdl-38781371

ABSTRACT

Apparent overabundance means theories of how galaxies took shape in the early universe may need adjusting.

9.
Nature ; 2024 Feb 12.
Article in English | MEDLINE | ID: mdl-38347212
10.
Nature ; 2023 Nov 13.
Article in English | MEDLINE | ID: mdl-37957348
11.
Nature ; 623(7989): 900, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37968468
13.
Nature ; 621(7978): 242, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37674093
14.
Nature ; 2023 Aug 21.
Article in English | MEDLINE | ID: mdl-37604864
16.
Lancet Oncol ; 24(6): 636-645, 2023 06.
Article in English | MEDLINE | ID: mdl-37269844

ABSTRACT

BACKGROUND: Cancer is a leading cause of disease burden globally, with more than 19·3 million cases and 10 million deaths recorded in 2020. Research is crucial to understanding the determinants of cancer and the effects of interventions, and to improving outcomes. We aimed to analyse global patterns of public and philanthropic investment in cancer research. METHODS: In this content analysis, we searched the UberResearch Dimensions database and Cancer Research UK data for human cancer research funding awards from public and philanthropic funders between Jan 1, 2016, and Dec 31, 2020. Included award types were project and programme grants, fellowships, pump priming, and pilot projects. Awards focused on operational delivery of cancer care were excluded. Awards were categorised by cancer type, cross-cutting research theme, and research phase. Funding amount was compared with global burden of specific cancers, measured by disability-adjusted life-years, years lived with disability, and mortality using data from the Global Burden of Disease study. FINDINGS: We identified 66 388 awards with total investment of about US$24·5 billion in 2016-20. Investment decreased year-on-year, with the largest drop observed between 2019 and 2020. Pre-clinical research received 73·5% of the funding across the 5 years ($18 billion), phase 1-4 clinical trials received 7·4% ($1·8 billion), public health research received 9·4% ($2·3 billion), and cross-disciplinary research received 5·0% ($1·2 billion). General cancer research received the largest investment ($7·1 billion, 29·2% of the total funding). The most highly funded cancer types were breast cancer ($2·7 billion [11·2%]), haematological cancer ($2·3 billion [9·4%]), and brain cancer ($1·3 billion [5·5%]). Analysis by cross-cutting theme revealed that 41·2% of investment ($9·6 billion) went to cancer biology research, 19·6% ($4·6 billion) to drug treatment research, and 12·1% ($2·8 billion) to immuno-oncology. 1·4% of the total funding ($0·3 billion) was spent on surgery research, 2·8% ($0·7 billion) was spent on radiotherapy research, and 0·5% ($0·1 billion) was spent on global health studies. INTERPRETATION: Cancer research funding must be aligned with the global burden of cancer with more equitable funding for cancer research in low-income and middle-income countries (which account for 80% of cancer burden), both to support research relevant to these settings, and build research capacity within these countries. There is an urgent need to prioritise investment in surgery and radiotherapy research given their primacy in the treatment of many solid tumours. FUNDING: None.


Subject(s)
Biomedical Research , Brain Neoplasms , Fund Raising , Humans , Financing, Organized , Investments , Global Health
17.
Clin Teach ; 20(2): e13563, 2023 04.
Article in English | MEDLINE | ID: mdl-36808878

ABSTRACT

BACKGROUND: The Medical Student Technician (MST) role is a paid position established in Northern Ireland in 2020. The Experience-Based Learning (ExBL) model is a contemporary medical education pedagogy advocating supported participation to develop capabilities important for doctors-to-be. In this study, we used the ExBL model to explore the experiences of MSTs and how the role contributed to students' professional development and preparedness for practice. METHODS: A convenience sampling strategy was used to recruit a total of 17 MSTs in three focus groups. Semi-structured interviews were transcribed verbatim and analysed using the ExBL model as a framework. Transcripts were independently analysed and coded by two investigators and discrepancies resolved with the remaining investigators. RESULTS: The MST experiences reflected the various components of the ExBL model. Students valued earning a salary; however, what students earned transcended the financial reward alone. This professional role enabled students to meaningfully contribute to patient care and have authentic interactions with patients and staff. This fostered a sense of feeling valued and increased self-efficacy amongst MSTs, helping them acquire various practical, intellectual and affective capabilities and subsequently demonstrate an increased confidence in their identities as future doctors. CONCLUSION: Paid clinical roles for medical students could present useful adjuncts to traditional clinical placements, benefiting both students and potentially healthcare systems. The practice-based learning experiences described appear to be underpinned by a novel social context where students can add value, be and feel valued and gain valuable capabilities that better prepare them for starting work as a doctor.


Subject(s)
Education, Medical , Students, Medical , Humans , Students, Medical/psychology , Problem-Based Learning , Salaries and Fringe Benefits , Delivery of Health Care
19.
Nature ; 613(7945): 625, 2023 01.
Article in English | MEDLINE | ID: mdl-36653621
SELECTION OF CITATIONS
SEARCH DETAIL